UnicoCell Biomed Co., Ltd. (TWSE: 6794)
Health Care · Biotechnology · TW
NT$71.60
-9.25% today · -10.5% 1Y
UnicoCell Biomed Co., Ltd. (TWSE: 6794) operates in the Biotechnology industry within the Health Care sector. The company is valued at $142.50M and employs 27 people.
Over the last twelve months the share price has lost 10.5%, trading between 65.60 and 93.20.
Tweenvest scores UnicoCell Biomed Co., Ltd. across four factors: quality 43/100, value 51/100, growth 100/100. Its strongest factor is growth.
6794 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $142.50M
- Revenue (TTM)
- $705.99K
- P/E
- —
- EPS
- -1.65
- Dividend yield
- —
- Beta (5Y)
- -0.23
- 52-week high
- NT$93.20
- 52-week low
- NT$65.60
- Avg volume (3M)
- —
- Shares outstanding
- 63.64M
- Employees
- 27
- Next earnings
- —
About UnicoCell Biomed Co., Ltd.
UnicoCell Biomed Co., Ltd., a Taiwanese enterprise, specializes in the research, development, and application of stem cell-based pharmaceuticals, advanced cell therapy techniques, and regenerative medical solutions. Their flagship product, ELIXCYTE, is presently undergoing Phase 2 clinical trials, targeting both osteoarthritis and chronic kidney disease. Beyond therapeutics, the company also offers UnicoVial, a specialized cryopreservation and drug containment system designed for cell therapy products, and provides a range of related testing services.
- ISIN
- TW0006794001
- Founded
- 2011
- Listed since
- May 13, 2024
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc.NasdaqGS: ABOS | $146.08M | $2.02 | -5.61% |
| CANbridge Pharmaceuticals Inc.SEHK: 1228 | $145.79M | HK$1.92 | -6.59% |
| Kangstem Biotech Co., Ltd.KOSDAQ: A217730 | $144.47M | ₩2,065.00 | -7.81% |
| Atrium Therapeutics, Inc.NasdaqGS: RNA | $143.69M | $8.21 | -2.26% |
| Outlook Therapeutics, Inc.NasdaqCM: OTLK | $142.44M | $0.59 | -2.30% |
| Cloudbreak Pharma Inc.SEHK: 2592 | $140.32M | HK$— | — |
| Anavex Life Sciences Corp.NasdaqGS: AVXL | $139.97M | $1.51 | +1.34% |
| Voyager Therapeutics, Inc.NasdaqGS: VYGR | $139.87M | $2.27 | -7.35% |
Figures last refreshed Oct 11, 2026.